Bioengineered ZnO/Activated Carbon Nanocomposites for Combating Multidrug-resistant Bacterial Strains
The present work highlights the superior physicochemical and antibacterial performance of BZNAC compared with BZN, underscoring the synergistic effect of AC inclusion and validating BZNAC as a therapeutic candidate against MDR bacterial infections, warranting further preclinical and clinical testing.